1.145USD-1.72%Mkt Cap: 450.88M USDP/E: —Last update: 2026-06-01
Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Amer…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap450.88M USD
Enterprise Value23.24M USD
Revenue (TTM)86.25M USD
Gross Profit42.54M USD
Net Income (TTM)-74.90M USD
Revenue/Share0.2250 USD
Last Price1.145 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees385
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-115.00
PEG—
EV/EBITDA-0.34
EV/Revenue0.27
P/S5.20
P/B0.80
EPS (TTM)-0.13
EPS (Forward)-0.01
52W Range
0.870032% of range1.720
52W High1.720 USD
52W Low0.8700 USD
Profitability
Gross Margin49.86%
Oper. Margin-44.53%
EBITDA Margin-79.08%
Profit Margin-87.77%
ROE-17.65%
ROA-13.19%
Growth
Revenue Growth4.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-74.34M USD
CapEx (TTM)8.30M USD
FCF Margin-15.58%
FCF Yield-2.98%
Net Debt-425.69M USD
Net Debt/EBITDA6.24
Balance Sheet
Debt/Equity0.07
Current Ratio12.36
Quick Ratio11.77
Book Value/Sh1.438 USD
Cash/Share1.166 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)1.550 USD
Target Range1.350 USD – 1.750 USD
# Analysts2
Ownership
Shares Out.390.37M
Float210.62M
Insiders1.47%
Institutions76.97%
Short Interest
Short Ratio5.2d
Short % Float5.48%
Short % Out.3.31%
Shares Short12.92M
Short (prev mo.)8.48M
Technical
SMA 500.9606 (+19.2%)
SMA 2001.219 (-6.1%)
Beta1.31
S&P 52W Chg27.94%
Avg Vol (30d)2.03M
Avg Vol (10d)1.62M
Technical Indicators
RSI (14)68.3
MACD0.0395
MACD Signal0.0250
MACD Hist.+0.0145
BB Upper1.131 USD
BB Middle1.018 USD
BB Lower0.9062 USD
BB Width22.05%
ATR (14)0.0556 USD
Vol Ratio (20d)1.00x